Skip to content

Clinical trials

Phase 2 Mucopolysaccharidosis III trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Mucopolysaccharidosis III Phase: Phase 2 Clear all

4 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20141
20151
20181

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed2
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Shire2
Allievex Corporation1
Masonic Cancer Center, University of Minnesota1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Mucopolysaccharidosis III4
Adrenoleukodystrophy1
Gangliosidosis, GM11
Leukodystrophy, Globoid Cell1
Leukodystrophy, Metachromatic1
Lysosomal Storage Diseases1
Metabolism, Inborn Errors1
Mucolipidoses1
Mucopolysaccharidoses1
Mucopolysaccharidosis II1

Trials

Showing 51 to 4 of 4. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.